Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study on Immediate Placement to Evaluate Astra Tech Osseospeed Implants in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Dentsply Implants
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00136149
First received: August 25, 2005
Last updated: February 1, 2013
Last verified: February 2013
  Purpose

This is a study to evaluate immediate implants.


Condition Intervention
Dental Implants
Procedure: Immediate implants

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open, Prospective, Controlled Study on Immediate Placement to Evaluate Clinical Outcome of Astra Tech Implants, Fixture Microthread Osseospeed in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Implant survival after 1 week, 3 weeks, 8 weeks, 10 weeks, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years [ Time Frame: after 1 week, 3 weeks, 8 weeks, 10 weeks, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 51
Study Start Date: January 2005
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Immediate implants Procedure: Immediate implants
Immediate implants are used.

Detailed Description:

Solitary replacement of teeth by implants in upper maxilla - immediate implants

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age or older

Exclusion Criteria:

  • Smoking
  • Medical risk patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00136149

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Dentsply Implants
Investigators
Principal Investigator: Hugo De Bruyn, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00136149     History of Changes
Other Study ID Numbers: 2004/439
Study First Received: August 25, 2005
Last Updated: February 1, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on November 20, 2014